Summa Silver Announces Closing of $6.5 Million Brokered Financing

In This Article:

Vancouver, British Columbia--(Newsfile Corp. - November 1, 2024) - Summa Silver Corp. (TSXV: SSVR) (OTCQX: SSVRF) (FSE: 48X) ("Summa" or the "Company" ) is pleased to announce the closing of its previously announced brokered offering (the "Offering") of units of the Company (each, a "Unit") at a price of $0.40 per Unit for aggregate gross proceeds of $6,483,000, including a partial exercise of the agents' option. The Offering was completed under a combined Listed Issuer Financing Exemption ("LIFE") private placement and concurrent private placement to accredited investors ("Private Placement").

The Offering was led by Research Capital Corporation and Eventus Capital Corp. as the co-lead agents and joint bookrunners, on behalf of a syndicate of agents, including Eight Capital (collectively, the "Agents").

Each Unit is comprised of one common share of the Company (a "Common Share") and one-half of one Common Share purchase warrant (each whole warrant, a "Warrant"). Each whole Warrant shall be exercisable to acquire one Common Share at a price of $0.55 per Common Share until November 1, 2026.

The net proceeds of the Offering will be used for further exploration work on the Company's projects and for general working capital purposes.

As part of the Offering, 12,500,000 Units ("LIFE Units") were sold to purchasers pursuant to the Listed Issuer Financing Exemption under Part 5A of National Instrument 45-106 - Prospectus Exemptions in all provinces of Canada, except Quebec, and other qualifying jurisdictions, including the United States. In addition, 3,707,500 Units ("Accredited Investor Units") were sold to accredited investors under the accredited investor exemption in all provinces of Canada, and other qualifying jurisdictions, including the United States. The LIFE Units offered are immediately "free-trading" under applicable Canadian securities laws. Unless permitted under securities legislation, the Accredited Investor Units cannot be traded before March 2, 2025.

In connection with the Offering, the Company paid to the Agents a cash commission of $399,525 and issued to the Agent 998,813 broker warrants (the "Broker Warrants"). In addition, the Agents received an advisory fee of $18,000 and 45,000 advisory broker warrants on the same terms as the Broker Warrants. Each Broker Warrant entitles the holder thereof to acquire one Common Share at a price of $0.40 per Common Share at any time on or before November 1, 2026.